Protein Fluidics, Inc.

At Protein Fluidics, we are commercializing assay automation platforms using novel microfluidic technologies in order to accelerate data driven decisions in the Life Sciences. We are passionate about providing scientists with the latest automation tools to help with the next breakthrough discovery in oncology, diagnostics, and more. We are located in the San Francisco Bay Area. We are privately held and have closed three rounds of funding from strategic investors. Cromwell has over 30 years of senior executive and technical expertise in numerous hi-tech industries. Prior to Protein Fluidics, Evan served as the President and CEO of California-based Blueshift Biotechnologies. Evan’s passion is integrating new technologies into products that provide unexpected value to customers in life sciences and other communities.